DAMP ES
Latest Information Update: 30 May 2001
At a glance
- Originator Nonindustrial sources
- Class Antineoplastics
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 14 Dec 1994 No-Development-Reported for Cancer (Unknown route)